Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 23 | 2026 | 706 | 3.780 |
Why?
|
| Caenorhabditis elegans Proteins | 20 | 2026 | 447 | 3.610 |
Why?
|
| GABAergic Neurons | 8 | 2026 | 38 | 2.490 |
Why?
|
| Synaptic Transmission | 10 | 2024 | 151 | 1.810 |
Why?
|
| Receptors, Nicotinic | 12 | 2026 | 69 | 1.730 |
Why?
|
| Synapses | 5 | 2026 | 195 | 1.690 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2022 | 24 | 1.250 |
Why?
|
| Neuropeptides | 2 | 2021 | 81 | 1.180 |
Why?
|
| Motor Neurons | 8 | 2024 | 218 | 1.160 |
Why?
|
| Neuromuscular Junction | 8 | 2018 | 83 | 1.160 |
Why?
|
| Receptors, Cholinergic | 6 | 2026 | 24 | 1.090 |
Why?
|
| Animals, Genetically Modified | 7 | 2018 | 310 | 0.840 |
Why?
|
| Behavior, Animal | 7 | 2017 | 234 | 0.800 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 428 | 0.750 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2024 | 137 | 0.720 |
Why?
|
| Nicotinic Antagonists | 6 | 2005 | 19 | 0.680 |
Why?
|
| Axons | 2 | 2022 | 123 | 0.630 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 282 | 0.600 |
Why?
|
| Animals | 31 | 2026 | 21308 | 0.590 |
Why?
|
| Cholinergic Neurons | 2 | 2024 | 10 | 0.570 |
Why?
|
| Locomotion | 5 | 2021 | 111 | 0.530 |
Why?
|
| Acetylcholine | 7 | 2018 | 48 | 0.520 |
Why?
|
| Oviposition | 1 | 2017 | 4 | 0.520 |
Why?
|
| Nerve Net | 1 | 2017 | 100 | 0.480 |
Why?
|
| Dendrites | 1 | 2016 | 60 | 0.470 |
Why?
|
| Cholecystokinin | 1 | 2014 | 10 | 0.430 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2014 | 24 | 0.430 |
Why?
|
| Dendritic Spines | 2 | 2026 | 12 | 0.420 |
Why?
|
| Movement | 2 | 2013 | 163 | 0.410 |
Why?
|
| Dopamine | 1 | 2014 | 108 | 0.410 |
Why?
|
| Neural Inhibition | 1 | 2013 | 30 | 0.380 |
Why?
|
| Electrophysiology | 6 | 2006 | 89 | 0.340 |
Why?
|
| Signal Transduction | 6 | 2024 | 3144 | 0.330 |
Why?
|
| Mutation | 9 | 2026 | 2658 | 0.330 |
Why?
|
| Motor Neuron Disease | 1 | 2010 | 28 | 0.330 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 68 | 0.320 |
Why?
|
| Cocaine | 2 | 2001 | 101 | 0.310 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 2006 | 7 | 0.290 |
Why?
|
| Neurons | 6 | 2016 | 933 | 0.280 |
Why?
|
| Muscles | 3 | 2006 | 179 | 0.280 |
Why?
|
| Patch-Clamp Techniques | 5 | 2013 | 133 | 0.260 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 150 | 0.250 |
Why?
|
| Receptors, AMPA | 4 | 2008 | 42 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2026 | 156 | 0.250 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2012 | 61 | 0.240 |
Why?
|
| Nicotine | 3 | 2005 | 118 | 0.230 |
Why?
|
| Receptors, FSH | 1 | 2024 | 8 | 0.220 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 361 | 0.210 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 773 | 0.200 |
Why?
|
| Amino Acid Sequence | 8 | 2013 | 1589 | 0.200 |
Why?
|
| Nicotinic Agonists | 2 | 2000 | 39 | 0.200 |
Why?
|
| Piperidines | 2 | 2005 | 73 | 0.190 |
Why?
|
| Oocytes | 8 | 2009 | 201 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 90 | 0.180 |
Why?
|
| Electric Stimulation | 4 | 2013 | 139 | 0.180 |
Why?
|
| Presynaptic Terminals | 1 | 2022 | 38 | 0.180 |
Why?
|
| Escape Reaction | 2 | 2013 | 8 | 0.170 |
Why?
|
| Tyramine | 2 | 2013 | 9 | 0.170 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 240 | 0.170 |
Why?
|
| Membrane Proteins | 4 | 2019 | 918 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2013 | 75 | 0.150 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 15 | 0.150 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2019 | 13 | 0.150 |
Why?
|
| Xenopus laevis | 5 | 2009 | 71 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2019 | 105 | 0.150 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 491 | 0.140 |
Why?
|
| Brain Mapping | 1 | 2020 | 240 | 0.140 |
Why?
|
| Membrane Potentials | 3 | 2009 | 138 | 0.140 |
Why?
|
| Calcium Channels | 3 | 2008 | 103 | 0.140 |
Why?
|
| Decanoic Acids | 1 | 1998 | 4 | 0.140 |
Why?
|
| Molecular Sequence Data | 8 | 2008 | 1979 | 0.140 |
Why?
|
| Metacognition | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 268 | 0.130 |
Why?
|
| Neurosecretion | 1 | 2017 | 2 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2020 | 275 | 0.130 |
Why?
|
| Serotonergic Neurons | 1 | 2017 | 5 | 0.130 |
Why?
|
| Ion Channel Gating | 2 | 2009 | 44 | 0.130 |
Why?
|
| Awareness | 1 | 2017 | 73 | 0.130 |
Why?
|
| Psychotherapy | 1 | 2017 | 102 | 0.130 |
Why?
|
| Serotonin | 1 | 2017 | 62 | 0.130 |
Why?
|
| Aldicarb | 2 | 2013 | 4 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2017 | 64 | 0.120 |
Why?
|
| Cations, Divalent | 1 | 1996 | 25 | 0.120 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2013 | 50 | 0.120 |
Why?
|
| Nerve Regeneration | 1 | 2016 | 38 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 3 | 2013 | 372 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2015 | 74 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1630 | 0.110 |
Why?
|
| Synaptic Vesicles | 2 | 2024 | 25 | 0.110 |
Why?
|
| Xenopus | 5 | 2006 | 55 | 0.110 |
Why?
|
| Regeneration | 1 | 2016 | 125 | 0.110 |
Why?
|
| Rats | 5 | 2005 | 1989 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 16 | 0.110 |
Why?
|
| Dopaminergic Neurons | 1 | 2014 | 37 | 0.100 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2188 | 0.100 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 8 | 0.100 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 46 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 42 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 129 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 384 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 1603 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 86 | 0.090 |
Why?
|
| Calnexin | 1 | 2010 | 5 | 0.080 |
Why?
|
| Calreticulin | 1 | 2010 | 4 | 0.080 |
Why?
|
| Paralysis | 1 | 2010 | 17 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 364 | 0.080 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 2 | 2012 | 3 | 0.080 |
Why?
|
| Ion Channels | 1 | 2010 | 92 | 0.080 |
Why?
|
| Necrosis | 1 | 2010 | 148 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 237 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2010 | 257 | 0.080 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2009 | 13 | 0.080 |
Why?
|
| Chloride Channels | 1 | 2009 | 28 | 0.070 |
Why?
|
| Calcium | 2 | 2019 | 581 | 0.070 |
Why?
|
| Humans | 7 | 2023 | 65100 | 0.070 |
Why?
|
| Cell Death | 1 | 2010 | 289 | 0.070 |
Why?
|
| Muscle Contraction | 2 | 2024 | 203 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2008 | 27 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2009 | 602 | 0.070 |
Why?
|
| Mecamylamine | 2 | 1999 | 14 | 0.070 |
Why?
|
| Homeostasis | 1 | 2010 | 378 | 0.070 |
Why?
|
| Insect Proteins | 1 | 2006 | 82 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2006 | 173 | 0.060 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Levamisole | 1 | 2005 | 7 | 0.060 |
Why?
|
| Choline | 1 | 2005 | 23 | 0.060 |
Why?
|
| Cholinergic Antagonists | 1 | 2005 | 32 | 0.060 |
Why?
|
| Heptanoic Acids | 1 | 2005 | 22 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 133 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 139 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2005 | 65 | 0.050 |
Why?
|
| Gene Expression | 2 | 2009 | 852 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2005 | 320 | 0.050 |
Why?
|
| Genome, Protozoan | 1 | 2003 | 15 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 17 | 0.050 |
Why?
|
| Interneurons | 1 | 2003 | 22 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 272 | 0.050 |
Why?
|
| Bungarotoxins | 1 | 2001 | 2 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2001 | 27 | 0.040 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2001 | 10 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 60 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2001 | 96 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 145 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 3762 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 2000 | 52 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 758 | 0.040 |
Why?
|
| Kinetics | 2 | 2006 | 759 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2020 | 102 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 701 | 0.040 |
Why?
|
| Female | 6 | 2019 | 34000 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 856 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 980 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2019 | 156 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1998 | 19 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 278 | 0.030 |
Why?
|
| Community Mental Health Centers | 1 | 2017 | 16 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 162 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 300 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 382 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 500 | 0.030 |
Why?
|
| Ganglionic Blockers | 1 | 1996 | 1 | 0.030 |
Why?
|
| Permeability | 1 | 1996 | 50 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 907 | 0.030 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2013 | 7 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2013 | 15 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 115 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2013 | 224 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 404 | 0.020 |
Why?
|
| Chromosome Pairing | 1 | 2012 | 7 | 0.020 |
Why?
|
| RNA | 1 | 1996 | 426 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 71 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2012 | 104 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 153 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2244 | 0.020 |
Why?
|
| Male | 3 | 2019 | 31017 | 0.020 |
Why?
|
| Neck Muscles | 1 | 2009 | 10 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2009 | 30 | 0.020 |
Why?
|
| Head Movements | 1 | 2009 | 9 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 31 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4810 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 111 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6305 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 202 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2008 | 135 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1552 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5784 | 0.020 |
Why?
|
| Bees | 1 | 2006 | 5 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2006 | 40 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2006 | 18 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 1329 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 349 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 128 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 103 | 0.010 |
Why?
|
| Plasmids | 1 | 2006 | 294 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 266 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 415 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 169 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 676 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2006 | 394 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 622 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 505 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2023 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17351 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 168 | 0.010 |
Why?
|
| Mice | 2 | 2005 | 11097 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1163 | 0.010 |
Why?
|